FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318479390> ?p ?o ?g. }

• W4318479390 endingPage "247" @default.
• W4318479390 startingPage "247" @default.
• W4318479390 abstract "Scleroderma or systemic sclerosis (SSc) is an autoimmune disease affecting the connective tissue, characterized by fibrosis of the skin and internal organs. There is currently no curative treatment available, so therapeutic action is aimed at a symptomatic treatment of the affected organs. The development of biotechnology has made it possible to implement certain biological drugs that could represent a window of opportunity to modulate the evolution and symptomatology of scleroderma with greater efficacy and less toxicity than conventional treatments. This study aimed to review the current evidence critically and systematically on the effects of biological drugs on the pulmonary function, skin disease, and health status of patients afflicted by diffuse cutaneous systemic sclerosis (dcSSc). Three electronic databases (Pubmed, Dialnet, and Cochrane Library Plus) were systematically searched until the cut-off date of October 2022. The review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and included original articles in English and Spanish with a controlled trial design, comparing biological drug treatments (tocilizumab, belimumab, riociguat, abatacept, and romilkimab) with a control group. The methodological quality of the studies was assessed using the McMaster quantitative form and the PEDro scale. A total of 383 studies were identified, 6 of them met the established criteria and were included in the present systematic review. A total of 426 patients treated with tocilizumab, belimumab, riociguat, abatacept, and romilkimab were included. The results showed substantial non-significant (p < 0.05) improvement trends after treatment with the biological drugs included in this review for the modified Rodnan Scale Value, Forced Vital Capacity, and Carbon Monoxide Diffusion Test; however, no benefits were shown on the Health Assessment Questionnaire–Disability Index when compared to the control group. Biological drugs, therefore, maybe a new therapeutic strategy for dcSSc and could be recommended as an additional and/or adjunctive treatment that promotes anti-fibrotic activity. This review could further define the clinical rationale for the use of biologics in the treatment of dcSSc and could provide key details on the study protocol, design, and outcome reporting." @default.
• W4318479390 created "2023-01-30" @default.
• W4318479390 creator A5007541454 @default.
• W4318479390 creator A5014174665 @default.
• W4318479390 creator A5021672513 @default.
• W4318479390 creator A5030272175 @default.
• W4318479390 creator A5041995767 @default.
• W4318479390 creator A5050016063 @default.
• W4318479390 creator A5065015286 @default.
• W4318479390 date "2023-01-27" @default.
• W4318479390 modified "2023-10-15" @default.
• W4318479390 title "Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review" @default.
• W4318479390 cites W1531955991 @default.
• W4318479390 cites W1983930880 @default.
• W4318479390 cites W1995707831 @default.
• W4318479390 cites W2010426653 @default.
• W4318479390 cites W2055919351 @default.
• W4318479390 cites W2073381161 @default.
• W4318479390 cites W2102968146 @default.
• W4318479390 cites W2118649165 @default.
• W4318479390 cites W2119590791 @default.
• W4318479390 cites W2133278576 @default.
• W4318479390 cites W2137071299 @default.
• W4318479390 cites W2138183967 @default.
• W4318479390 cites W2153233962 @default.
• W4318479390 cites W2159053368 @default.
• W4318479390 cites W2342581347 @default.
• W4318479390 cites W2403047484 @default.
• W4318479390 cites W2508060872 @default.
• W4318479390 cites W2589893823 @default.
• W4318479390 cites W2590564118 @default.
• W4318479390 cites W2735328801 @default.
• W4318479390 cites W2766145635 @default.
• W4318479390 cites W2767061054 @default.
• W4318479390 cites W2792432524 @default.
• W4318479390 cites W2795983487 @default.
• W4318479390 cites W2804710412 @default.
• W4318479390 cites W2806476436 @default.
• W4318479390 cites W2955765694 @default.
• W4318479390 cites W2963254827 @default.
• W4318479390 cites W2968018599 @default.
• W4318479390 cites W2978537590 @default.
• W4318479390 cites W2981624279 @default.
• W4318479390 cites W2982587776 @default.
• W4318479390 cites W3016646661 @default.
• W4318479390 cites W3043068527 @default.
• W4318479390 cites W3048948521 @default.
• W4318479390 cites W3088045880 @default.
• W4318479390 cites W3094273359 @default.
• W4318479390 cites W3097881424 @default.
• W4318479390 cites W3108665643 @default.
• W4318479390 cites W3118356818 @default.
• W4318479390 cites W3123893780 @default.
• W4318479390 cites W3157708739 @default.
• W4318479390 cites W3216804304 @default.
• W4318479390 cites W4221036839 @default.
• W4318479390 cites W4226161621 @default.
• W4318479390 cites W4229377665 @default.
• W4318479390 cites W4291674810 @default.
• W4318479390 cites W4308620482 @default.
• W4318479390 doi "https://doi.org/10.3390/medicina59020247" @default.
• W4318479390 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36837449" @default.
• W4318479390 hasPublicationYear "2023" @default.
• W4318479390 type Work @default.
• W4318479390 citedByCount "0" @default.
• W4318479390 crossrefType "journal-article" @default.
• W4318479390 hasAuthorship W4318479390A5007541454 @default.
• W4318479390 hasAuthorship W4318479390A5014174665 @default.
• W4318479390 hasAuthorship W4318479390A5021672513 @default.
• W4318479390 hasAuthorship W4318479390A5030272175 @default.
• W4318479390 hasAuthorship W4318479390A5041995767 @default.
• W4318479390 hasAuthorship W4318479390A5050016063 @default.
• W4318479390 hasAuthorship W4318479390A5065015286 @default.
• W4318479390 hasBestOaLocation W43184793901 @default.
• W4318479390 hasConcept C126322002 @default.
• W4318479390 hasConcept C142724271 @default.
• W4318479390 hasConcept C159110408 @default.
• W4318479390 hasConcept C168563851 @default.
• W4318479390 hasConcept C173803235 @default.
• W4318479390 hasConcept C17744445 @default.
• W4318479390 hasConcept C177713679 @default.
• W4318479390 hasConcept C180032290 @default.
• W4318479390 hasConcept C189708586 @default.
• W4318479390 hasConcept C199539241 @default.
• W4318479390 hasConcept C2776304953 @default.
• W4318479390 hasConcept C2776478404 @default.
• W4318479390 hasConcept C2776670291 @default.
• W4318479390 hasConcept C2777178219 @default.
• W4318479390 hasConcept C2777575956 @default.
• W4318479390 hasConcept C2778886723 @default.
• W4318479390 hasConcept C2779075594 @default.
• W4318479390 hasConcept C2779134260 @default.
• W4318479390 hasConcept C2779338263 @default.
• W4318479390 hasConcept C2779473830 @default.
• W4318479390 hasConcept C2779605438 @default.
• W4318479390 hasConcept C2779951463 @default.
• W4318479390 hasConcept C2779967694 @default.
• W4318479390 hasConcept C2780653079 @default.

• next